Botfet / Company detail

KNSA

universe

Kiniksa Pharmaceuticals International, plc

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic8.2%

Gross Margin54.6%

Revenue Cagr104.8%

Fcf Conversion43.1%

Fcf Yield0.4%

Interest Coverage0.0x

Market Cap B$5.8B

Pe71.7

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener